INFU - Paul A. Gendron At InfuSystems Holdings Acquires Stock Options | Benzinga
Paul A. Gendron, Director at InfuSystems Holdings (AMEX:INFU), reported acquisition of company stock options on May 21, according to a new SEC filing.
What Happened: Uncovered in a Form 4 filing on Tuesday with the U.S. Securities and Exchange Commission, Gendron, Director at InfuSystems Holdings, executed an insider options move. This move consisted of acquiring stock options for 35,685 shares of INFU, granting Gendron the right to purchase the company's stock at an exercise price of $6.34 per share.
InfuSystems Holdings shares are currently trading up by 0.6%, with a current price of $6.67 as of Wednesday morning. This brings the total value of Gendron's 35,685 shares to $11,776.
Get to Know InfuSystems Holdings Better
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The first platform is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second platform, Device Solutions, supports the Patient Services platform and leverages strong service orientation to win incremental business from its direct payer clients. The Device segment is comprised of ...